
Ampio Pharmaceuticals launches clinical trial of Ampion for treatment of osteoarthritis of the hand
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced patient dosing has begun in the initial clinical trial of Ampion for the treatment of pain due to osteoarthritis of the... Read More
Tuesday May 10, 2016